X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ·Healthcare·Biotechnology
$4.01
+1.91%
Mkt Cap $363.13M
Analyst Ratings
No recent rating data.
Price Target (9 analysts)
$12.00
Range $12.00 – $12.00
Implied Upside
+199.6%
Consensus $12.00 vs current $4.01
NASDAQ·Healthcare·Biotechnology
$4.01
+1.91%
Mkt Cap $363.13M
No recent rating data.
Price Target (9 analysts)
$12.00
Range $12.00 – $12.00
+199.6%
Consensus $12.00 vs current $4.01